Long-Term Dupilumab Efficacy and Safety in Moderate-to-Severe Atopic Dermatitis: A Real-World Single-Center Retrospective Study

Name: Long-Term Dupilumab Efficacy and Safety in Moderate-to-Severe Atopic Dermatitis: A Real-World Single-Center Retrospective Study
Creator: YUN QIU
Published: 2025-12-08T11:25:07.379Z
Keywords: Atopic Dermatitis

QIU, YUN; Ding, Yuan; Hu, Wen; Wang, Hongjuan; Lei, Zixian; Kang, Xiaojing

doi:10.17632/nbw58bcg38.1

Long-Term Dupilumab Efficacy and Safety in Moderate-to-Severe Atopic Dermatitis: A Real-World Single-Center Retrospective Study

Published: 8 December 2025| Version 1 | DOI: 10.17632/nbw58bcg38.1

Contributors:

YUN QIU, Yuan Ding, Wen Hu, Hongjuan Wang, Zixian Lei, Xiaojing Kang

Description

This is the original drawing and notes of the pictures and tables supplemented in this article：Long-Term Dupilumab Efficacy and Safety in Moderate-to-Severe Atopic Dermatitis: A Real-World Single-Center Retrospective Study

Long-Term Dupilumab Efficacy and Safety in Moderate-to-Severe Atopic Dermatitis: A Real-World Single-Center Retrospective Study

Description

Files

Categories

Licence